List of the top somatic mutation targets in Chinese DLBCLs. Genes affected by nonsilent, somatically occurring mutations in ≥5 DLBCL samples in the discovery cohort (5% of 96 cases) and considered to be significantly mutated (q value < 0.1) are displayed. Novel significant mutation targets identified in our cohort are marked with an asterisk (red). IPI, international prognostic index; LDH, lactate dehydrogenase (level); P/R, primary/relapse.